Qsemble Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,353
Closed -$305K 525
2025
Q2
$305K Sell
2,353
-321
-12% -$46.5K 0.03% 368
2025
Q1
$426K Buy
2,674
+633
+31% +$115K 0.05% 322
2024
Q4
$378K Buy
+2,041
New +$396K 0.05% 312
2024
Q2
Sell
-2,344
Closed -$503K 494
2024
Q1
$503K Sell
2,344
-1,909
-45% -$374K 0.11% 272
2023
Q4
$865K Buy
4,253
+105
+3% +$17K 0.22% 168
2023
Q3
$823K Buy
+4,148
New +$1.05M 0.15% 195
2023
Q2
Sell
-1,400
Closed -$328K 271
2023
Q1
$328K Buy
+1,400
New +$354K 0.22% 161

Other funds holding INSP

Qsemble Capital Management's INSP Position: Q3 2025 in Review

Qsemble Capital Management sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 2,353 shares — an estimated $305K sold.

Qsemble Capital Management first reported a position in INSP in Q1 2023 and held it in 7 quarters. The position peaked at $865K in Q4 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Qsemble Capital Management reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Qsemble Capital Management sold 2,353 Inspire Medical Systems shares in Q3 2025, an estimated $305K.
  • Qsemble Capital Management first reported a position in Inspire Medical Systems in Q1 2023 and held it in 7 quarters.
  • Qsemble Capital Management's Inspire Medical Systems position peaked at $865K in Q4 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Qsemble Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.